|
Index of reports
> Cases resulting in other serious reactions (42)
Below is the selection of adverse event reports related to Zerit (Stavudine) that includes cases resulting in other serious reactions.
Reports 1 - 25 of 42 Next >>
Adverse event in 71 year old male receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-10-22
Patient: 71 year old male, weighing 53.0 kg (116.6 pounds)
Adverse reactions / side effects: Neuropathy, Renal Tubular Disorder, Vitamin D Deficiency, Blood Parathyroid Hormone Increased
Suspect drug(s):
Kaletra
Start date: 2002-03-01
Plaquenil
Sustiva
Start date: 2002-03-01
Videx
Viread
Start date: 2002-03-01
Zerit
Other drugs received by patient: Virlix; Tenormin; Corvasal; Aspegic 325; Omeprazole
Adverse event in male receiving Zerit (Stavudine)
Reported by a consumer/non-health professional from United Kingdom on 2007-07-27
Patient: male
Adverse reactions / side effects: Hepatic Cirrhosis
Suspect drug(s):
Sustiva
Videx
Zerit
Adverse event in 49 year old male receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-07-20
Patient: 49 year old male, weighing 52.0 kg (114.4 pounds)
Adverse reactions / side effects: Weight Decreased, Speech Disorder, Pancreatitis Acute, Vomiting, Nausea, Diabetes Mellitus, Lactic Acidosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Kaletra
Indication: HIV Infection
Start date: 2007-04-15
End date: 2007-06-13
Kivexa
Indication: HIV Infection
Start date: 2007-04-15
End date: 2007-06-13
Videx
Administration route: Oral
Indication: HIV Infection
Start date: 1998-04-01
End date: 2006-12-09
Viracept
Indication: HIV Infection
Start date: 1998-04-01
End date: 2006-12-09
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 1998-04-01
End date: 2006-12-09
Other drugs received by patient: Bactrim; Lipanthyl; Rivotril; Laroxyl
Adverse event in 28 year old female receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from Botswana on 2007-07-06
Patient: 28 year old female
Adverse reactions / side effects: Abortion Induced
Suspect drug(s):
Combivir
Administration route: Oral
Indication: HIV Infection
Start date: 2004-02-23
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-18
Viramune
Administration route: Oral
Indication: HIV Infection
Start date: 2004-03-08
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-18
Adverse event in 41 year old male receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-05
Patient: 41 year old male
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Hyperlipidaemia, Hepatic Function Abnormal, Gamma-Glutamyltransferase Increased, Pancytopenia
Suspect drug(s):
Efavirenz
Administration route: Oral
Indication: HIV Infection
Start date: 2001-12-08
Epiver
Dosage: 150 mg twice daily 03-jul-2004 to 02-jul-2000; 300 mg daily 03-jul-2004-continue
Administration route: Oral
Indication: HIV Infection
Start date: 2001-12-08
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 1999-01-23
End date: 2001-12-07
PEG-Intron
Indication: Hepatitis C
Start date: 2005-01-19
Rebetol
Dosage: 200 mg in the morning and 400 mg in the afternoon.
Administration route: Oral
Indication: Hepatitis C
Start date: 2005-01-19
End date: 2006-11-16
Videx
Administration route: Oral
Indication: HIV Infection
Start date: 1992-09-04
End date: 2001-04-16
Videx EC
Administration route: Oral
Indication: HIV Infection
Start date: 2001-04-17
End date: 2001-12-07
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 2001-12-08
End date: 2004-07-02
Other drugs received by patient: Kogenate
Adverse event in male receiving Zerit (Stavudine)
Reported by a physician from United Kingdom on 2007-06-25
Patient: male
Adverse reactions / side effects: Hepatic Fibrosis
Suspect drug(s):
Videx
Administration route: Oral
Zerit
Adverse event in male receiving Zerit (Stavudine)
Reported by a consumer/non-health professional from United States on 2007-06-20
Patient: male
Adverse reactions / side effects: Hepatic Cirrhosis
Suspect drug(s):
Videx
Zerit
Adverse event in female receiving Zerit (Stavudine)
Reported by a consumer/non-health professional from United States on 2007-06-14
Patient: female
Adverse reactions / side effects: Electroencephalogram Abnormal, Cerebral Disorder, Drug Exposure During Pregnancy, Rhinitis, Neutropenia, Foetal Growth Retardation, Anaemia Macrocytic
Adverse event resulted in: hospitalization
Suspect drug(s):
Crixivan
Dosage: ongoing gestational week 2 through 10
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Epivir
Dosage: initiated at gestational week 29
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Epivir
Dosage: 6 week course after birth
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Fortovase
Dosage: initiated at gestational week 29
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Retrovir
Dosage: initiated at gestational week 10
Indication: HIV Test Positive
Start date: 1997-07-01
End date: 1998-01-19
Retrovir
Dosage: infusion at delivery
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Videx
Dosage: ongoing at gestational weeks 2 through 10
Indication: HIV Infection
Start date: 1997-05-29
End date: 1997-07-01
Zerit
Dosage: ongoing gestational weeks 2 through 10
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Adverse event in 38 year old male receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from Canada on 2007-06-08
Patient: 38 year old male
Adverse reactions / side effects: Hepatomegaly, Hepatotoxicity, Liver Function Test Abnormal
Suspect drug(s):
Lamivudine
Dosage: 150mg twice per day
Indication: Drug USE FOR Unknown Indication
Norvir
Dosage: 600mg twice per day
Indication: Drug USE FOR Unknown Indication
Zerit
Dosage: 40mg twice per day
Indication: Drug USE FOR Unknown Indication
Adverse event in female receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-30
Patient: female, weighing 1.0 kg (2.2 pounds)
Adverse reactions / side effects: Ileostomy, Premature Baby, Alanine Aminotransferase Increased, Thrombocythaemia, Necrotising Colitis, Speech Disorder, Colectomy Total, Blood Creatinine Increased, Enterocolitis, Pregnancy
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Invirase
Dosage: exposure during gestation.
Norvir
Dosage: exposure during gestation.
Retrovir
Dosage: exposure during delivery.
Start date: 1999-07-02
End date: 1999-07-02
Retrovir
Dosage: initiated at 8 mg/kg/day, 6 mg/kg/day from 7/6/99, then 1.4 mg/kg twice daily from 7/11/99.
Indication: Prophylaxis
Start date: 1999-07-02
End date: 1999-08-10
Retrovir
Administration route: Oral
Start date: 1999-07-07
End date: 1999-07-18
Videx
Dosage: exposure during gestation.
Zerit
Dosage: exposure during gestation.
Other drugs received by patient: Bactrim; Triflucan; Loxen; Celestene; Salbutamol
Adverse event in 33 year old female receiving Zerit (Stavudine)
Reported by a consumer/non-health professional from Japan on 2007-05-29
Patient: 33 year old female
Adverse reactions / side effects: Normal Newborn, Musculoskeletal Pain, Anaemia, Blood Triglycerides Increased, Pregnancy, Deep Vein Thrombosis
Suspect drug(s):
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 1999-02-03
Viracept
Dosage: viracept (nfv) 2200-2500 mg/day dosed
Administration route: Oral
Indication: HIV Infection
Start date: 1999-02-10
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 1999-02-03
Other drugs received by patient: Retrovir
Adverse event in female receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-05-25
Patient: female, weighing 3.0 kg (6.6 pounds)
Adverse reactions / side effects: Abdominal Pain, Blood Creatine Phosphokinase Increased, Hyperlactacidaemia, Flatulence, Mucous Stools, Platelet Count Increased, Hypercholesterolaemia, Hepatomegaly, Malaise, Obesity, Abdominal Distension, Hypertriglyceridaemia, Oxygen Saturation Decreased, Anaemia, Ventricular Tachycardia, Hypotonia, Neutropenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Fortovase
Dosage: received from week 27 of gestation to delivery
Invirase
Dosage: initiated at 27 weeks of gestation
Indication: HIV Infection
Norvir
Dosage: received from week 27 of gestation to delivery
Retrovir
Dosage: received 6 weeks of antiretroviral therapy after delivery, 200mg/20ml
Retrovir
Dosage: received from conception to day 3 of gestation and from week 27 of gestation to and at delivery.
Sustiva
Videx
Dosage: received from conception to day 3 of gestation, then from week 27 of gestation to delivery
Viramune
Dosage: received one single oral dose, from 27 weeks gestation transplacental exposure
Administration route: Oral
Indication: HIV Infection
Viramune
Dosage: received infusion during delivery,
Zerit
Other drugs received by patient: Cordarone; Speciafoldine; Ferrostrane; Uvesterol D; Fluorex; AZT
Adverse event in 38 year old female receiving Zerit (Stavudine)
Reported by a individual with unspecified qualification from United States on 2007-05-18
Patient: 38 year old female
Adverse reactions / side effects: Stillbirth
Suspect drug(s):
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-12-16
Epivir
Administration route: Oral
Start date: 2003-05-23
End date: 2005-11-11
Viramune
Administration route: Oral
Indication: HIV Infection
Start date: 2005-12-16
Viramune
Administration route: Oral
Start date: 2005-10-28
End date: 2005-11-11
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2005-12-16
Viread
Administration route: Oral
Start date: 2003-05-23
End date: 2005-11-11
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-22
End date: 2005-10-28
Zerit
Administration route: Oral
Start date: 2003-05-23
End date: 2005-03-21
Adverse event in 32 year old female receiving Zerit (Stavudine)
Reported by a individual with unspecified qualification from United States on 2007-05-18
Patient: 32 year old female
Adverse reactions / side effects: Stillbirth
Suspect drug(s):
Combivir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-14
End date: 2006-07-06
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2006-07-06
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-14
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 2006-07-06
Adverse event in 38 year old female receiving Zerit (Stavudine)
Reported by a individual with unspecified qualification from United States on 2007-05-18
Patient: 38 year old female
Adverse reactions / side effects: Abortion Spontaneous
Suspect drug(s):
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2004-08-19
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-10
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 2004-08-19
Adverse event in 38 year old male receiving Zerit (Stavudine)
Reported by a physician from United States on 2007-05-18
Patient: 38 year old male
Adverse reactions / side effects: Abdominal Pain, Immune Reconstitution Syndrome
Adverse event resulted in: hospitalization
Suspect drug(s):
Mk0518
Administration route: Oral
Indication: HIV Infection
Prezista
Administration route: Oral
Indication: HIV Infection
Ritonavir
Indication: HIV Infection
Truvada
Indication: HIV Infection
Zerit
Indication: HIV Infection
Ziagen
Indication: HIV Infection
Other drugs received by patient: Valcyte; Bactrim DS; Zyvox
Adverse event in 33 year old female receiving Zerit (Stavudine)
Reported by a consumer/non-health professional from Japan on 2007-05-01
Patient: 33 year old female
Adverse reactions / side effects: Anaemia, Musculoskeletal Pain, Blood Triglycerides Increased, Pregnancy, Deep Vein Thrombosis, Infant
Suspect drug(s):
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 1999-02-03
Viracept
Dosage: viracept (nfv) 2200-2500 mg/day dosed
Administration route: Oral
Indication: HIV Infection
Start date: 1999-02-10
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 1999-02-03
Adverse event in 49 year old male receiving Zerit (Stavudine)
Reported by a consumer/non-health professional from United States on 2007-04-30
Patient: 49 year old male, weighing 87.0 kg (191.4 pounds)
Adverse reactions / side effects: Disorientation, Hepatitis, Amnesia, Somnolence, Neuropathy Peripheral, Fatigue, Visual Disturbance, Balance Disorder, Chest Pain, Pancreatitis, Myocardial Infarction, Hypertension
Adverse event resulted in: disablity
Suspect drug(s):
Epivir
Indication: HIV Infection
Videx
Dosage: therapy start date: 1997 or 1998
Indication: HIV Infection
Viracept
Dosage: therapy start date: 1997 or 1998
Indication: HIV Infection
Viread
Indication: HIV Infection
Zerit
Dosage: therapy start date: 1997 or 1998
Indication: HIV Infection
End date: 2003-08-01
Other drugs received by patient: Centrum
Adverse event in 32 year old female receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from Botswana on 2007-04-20
Patient: 32 year old female
Adverse reactions / side effects: Abortion Induced
Suspect drug(s):
Combivir
Dosage: 2tab per day
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-16
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2003-08-19
Retrovir
Dosage: 600mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2004-08-18
Sustiva
Dosage: 600mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2003-08-19
Viramune
Dosage: 200mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2005-12-07
Zerit
Dosage: 80mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2003-08-19
Ziagen
Dosage: 600mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2005-10-26
Adverse event in 32 year old female receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from Botswana on 2007-04-17
Patient: 32 year old female
Adverse reactions / side effects: Abortion Spontaneous
Suspect drug(s):
Combivir
Dosage: 2tab per day
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-16
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2003-08-19
Retrovir
Dosage: 600mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2004-08-18
Sustiva
Dosage: 600mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2003-08-19
Viramune
Dosage: 200mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2005-12-07
Zerit
Dosage: 80mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2003-08-19
Ziagen
Dosage: 600mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2005-10-26
Adverse event in female receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from Botswana on 2007-04-06
Patient: female, weighing 2.8 kg (6.1 pounds)
Adverse reactions / side effects: Skin Hypopigmentation, Umbilical Hernia
Suspect drug(s):
Epivir
Indication: HIV Infection
Start date: 2003-09-19
Viramune
Indication: HIV Infection
Start date: 2003-10-03
Zerit
Indication: HIV Infection
Start date: 2003-09-19
Adverse event in 33 year old male receiving Zerit (Stavudine)
Reported by a consumer/non-health professional from United States on 2007-04-04
Patient: 33 year old male
Adverse reactions / side effects: Glucose Tolerance Impaired
Suspect drug(s):
Efavirenz
Administration route: Oral
Indication: HIV Infection
Start date: 2004-10-19
End date: 2005-04-04
Epivir
Dosage: started 13-sep-04 stopped 18-oct-04. restarted 12-jan-05
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2005-04-04
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-27
End date: 2004-10-18
Predonine
Dosage: iv(50 mg/d 23/09/04,60mg/d from 24to26/09/04)po titrated from 30mgx2/d on 30/09/04 to 5mg/d 02/12/04
Indication: Drug Eruption
Start date: 2004-09-23
End date: 2004-09-26
Viramune
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2004-09-26
Zerit
Dosage: dosed from 13-sep-04 to 18-oct-04. restarted 09-mar-05, 80 mg on 01-apr-2005
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2005-04-04
Other drugs received by patient: Combivir; Clarithromycin; Allelock; Solu-Medrol; Baktar; Viread; Adriamycin PFS; Clarithromycin; Doxorubicin HCL; Olopatadine HCL; Sulfamethoxazole + Trimethoprim
Adverse event in 33 year old male receiving Zerit (Stavudine)
Reported by a physician from Japan on 2007-04-03
Patient: 33 year old male
Adverse reactions / side effects: Drug Eruption, Anaemia, Glucose Tolerance Impaired
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Combivir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-10-19
End date: 2005-01-11
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-09-13
Kaletra
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-09-27
End date: 2004-10-18
Viramune
Dosage: 400mg per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-09-13
End date: 2004-09-26
Zerit
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-09-13
End date: 2004-10-18
Other drugs received by patient: Stocrin; Viread; Clarithromycin; Baktar; Unknown Drug; Ciprofloxacin; Ebutol
Adverse event in 37 year old male receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-04-02
Patient: 37 year old male
Adverse reactions / side effects: Vomiting, Overdose, Depressed Level of Consciousness, Suicide Attempt, Depression, Lipodystrophy Acquired
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Dosage: 300 mg daily normal daily dosage stopped in may-2001, restarted on an unspecified date
Administration route: Oral
Indication: HIV Infection
Start date: 2001-04-01
End date: 2005-11-15
Epivir
Administration route: Oral
Start date: 2005-11-16
End date: 2005-11-16
Stocrin Caps
Dosage: normal dosage 600 mg daily
Administration route: Oral
Indication: HIV Infection
Start date: 2001-04-01
End date: 2005-11-15
Stocrin Caps
Administration route: Oral
Start date: 2005-11-16
End date: 2005-11-16
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-01
End date: 2005-11-15
Viread
Administration route: Oral
Start date: 2005-11-16
End date: 2005-11-16
Zerit
Dosage: stopped in apr-2005, restarted on an unspecified date
Administration route: Oral
Indication: HIV Infection
Start date: 2001-04-01
End date: 2005-11-16
Other drugs received by patient: Rhythmy; Valtrex
Adverse event in male receiving Zerit (Stavudine)
Reported by a individual with unspecified qualification from Japan on 2007-04-02
Patient: male
Adverse reactions / side effects: Hepatitis C
Suspect drug(s):
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 1997-09-01
End date: 1998-08-10
Epivir
Administration route: Oral
Start date: 1998-11-02
End date: 2001-08-01
Epivir
Administration route: Oral
Start date: 2002-01-23
End date: 2006-01-03
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2006-01-04
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2004-03-10
End date: 2006-01-03
Reyataz
Administration route: Oral
Start date: 2006-01-04
Truvada
Administration route: Oral
Indication: HIV Infection
Start date: 2006-01-04
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 1998-09-22
End date: 2001-10-22
Zerit
Administration route: Oral
Start date: 2002-01-23
End date: 2006-01-03
Other drugs received by patient: Cross Eight M
Page 1 Next >>
|
